AI Pulse by Inblix

OpenAI drops GPT‑5: 700M weekly users and Amgen are already in

OpenAI Blog · Jul 13, 2026 · 2 min read · Read original article →

Curated by the Inblix editorial team


Featured image for article: OpenAI drops GPT‑5: 700M weekly users and Amgen are already in

OpenAI just pulled the curtain back on GPT‑5, and the positioning is unmistakably enterprise-first. The company isn’t just touting smarter text generation; they’re calling this their most unified model yet, merging the conversational fluency of 4o, the chain-of-thought reasoning from the o-series, and native agentic capabilities into a single system. The early access list reads like a who’s who of the Fortune 500—Morgan Stanley, SoftBank, Lowe’s, and T-Mobile are named alongside 5 million paid business users who have already integrated ChatGPT into their workflows. That’s a significant base to build on, but the real pressure is on the model to justify the upgrade cycle.

What’s genuinely interesting is the Amgen quote. The biotech giant says GPT‑5 cleared their internal bar for scientific accuracy—a notoriously high hurdle where hallucinations aren’t just annoying, they’re dangerous. The quote suggests the model is doing a better job navigating ambiguity where context matters, which points to improvements in structured thinking and reliability rather than just raw creative flair. For heavily regulated industries that have been waiting on the sidelines, that specific signal matters more than any generic benchmark score.

The timing aligns with nearly 700 million weekly active users on ChatGPT, a staggering number that puts consumer comfort with AI at an all-time high. OpenAI’s bet is that enterprise adoption will now accelerate because the workforce is already using the tools at home. The product rollout is staged: Team users get access today, with Enterprise and Edu following next week. A higher-octane GPT‑5 Pro tier with extended reasoning is also on the near-term roadmap for paying customers.

I’m watching two things closely here. First, the API performance on agents and coding—because if that doesn’t deliver a clear ROI over 4o, developer loyalty could fray. Second, the claim of a ‘unified’ experience. Merging reasoning models and standard models under one hood is an architectural flex if it works seamlessly. If it doesn’t, users will notice the seams immediately and wonder why they’re paying for a jack-of-all-trades that stumbles on tasks specialized models already handle well.

💡 Key Takeaways

  1. GPT‑5 merges OpenAI's conversational, reasoning, and agentic capabilities into a single model, aiming to eliminate the need for users to choose between different model families.
  2. Amgen's early testing indicates GPT‑5 meets the biotech industry's extremely high bar for scientific accuracy, particularly in navigating ambiguous, context-heavy scenarios.
  3. With nearly 700 million weekly ChatGPT users, OpenAI is betting that consumer familiarity will directly fuel enterprise deployment and productivity gains.
  4. A GPT‑5 Pro tier with extended reasoning is in the pipeline, suggesting OpenAI is segmenting the market between standard business use and deep analytical work.

Keep reading: See related articles below for more coverage on this topic.

Get smarter about AI

The sharpest AI news, curated daily. Delivered free to your inbox.

Learn more

Glossary terms

← Back to all articles